Kinomica Limited

Striving to improve patient outcomes by introducing our disruptive technologies for precision medicine

Kinomica offers KinoScan™, a powerful combination of advanced proprietary bioinformatics and LC-MS/MS phospho-proteomics to investigate global cellular signalling activities and reprogramming of biochemical network circuitries, for a range of applications, including:

  • Basic Research
    • determination of disease mechanisms
    • improve drug target & biomarker identification
  • Drug Discovery
    • improved monitoring of drug molecular efficacy and response (i.e. reveal mode of action / identify mechanism of resistance) in preclinical models
    • improve compound selection and optimisation at preclinical stage, to de-risk downstream therapeutic R&D pipelines
  • Drug Development & Post Launch
    • improved monitoring of drug molecular efficacy and response (i.e. reveal mode of action / identify mechanism of resistance) in human tissue / biopsies
    • discover & validate appropriate patient selection biomarkers for companion diagnostics
    • identify likely responders to therapy / improve and enhance patient stratification